Study guide

2.7 Lipids, Lipoproteins, and the Friedewald LDL Calculation

AMT Medical Laboratory Scientist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: General Laboratory Operations, Safety & Quality

1.1 Laboratory Safety, OSHA Standards, Hazard Communication, and Biohazard Control 1.2 Quality Systems, Quality Control, and Westgard Rules Interpretation 1.3 Specimen Collection, Handling, Order of Draw, and Phlebotomy Complications 1.4 Laboratory Instrumentation, Photometry, Spectrophotometry, and Centrifugation 1.5 Laboratory Mathematics, Dilutions, Solution Preparation, and Standard Curves 1.6 Regulatory Compliance, CLIA '88 Regulations, Accreditation, and Laboratory Ethics

2 Chapter 2: Clinical Chemistry & Metabolic Testing

2.1 Carbohydrate Metabolism, Glucose Regulation, Diabetes Mellitus, and HbA1c 2.2 Proteins, Non-Protein Nitrogenous Compounds (BUN, Creatinine, Uric Acid), and Renal Function 2.3 Enzymology and Organ Systems 2.4 Electrolytes, Acid-Base Balance, Anion Gap, and Blood Gas Analysis 2.5 Clinical Endocrinology, Thyroid, Adrenal, and Reproductive Hormones 2.6 Clinical Toxicology, Therapeutic Drug Monitoring (TDM), and Pharmacokinetics 2.7 Lipids, Lipoproteins, and the Friedewald LDL Calculation

3 Chapter 3: Hematology & Leukocyte Disorders

3.1 RBC Indices and Anemia 3.2 WBC Differential and Benign Disorders 3.3 Hematologic Malignancies 3.4 Hemoglobin Structure, Hemoglobinopathies (Sickle Cell, Thalassemia), and Variants 3.5 Hematology Automation, Flow Cytometry, and Cell Counting Technology

4 Chapter 4: Coagulation & Hemostasis

4.1 Primary and Secondary Hemostasis, Platelet Function, and Vascular Integrity 4.2 Coagulation Cascade Disorders 4.3 Coagulation Testing and Anticoagulants

5 Chapter 5: Immunology & Serology

5.1 Immune Mechanisms, Hypersensitivity Reactions, and Autoimmune Disease Testing 5.2 Serological Testing Principles and Infectious Serology

6 Chapter 6: Immunohematology & Blood Grouping

6.1 ABO and Rh Blood Group Systems, Antigens, Subgroups, and Weak D Variant 6.2 Red Cell Antibody Screening, Identification Panels, and Dosage Effects 6.3 Direct and Indirect Antiglobulin Testing (DAT/IAT) and Troubleshooting 6.4 Compatibility Testing, Crossmatching, and Hemolytic Disease of the Fetus and Newborn

7 Chapter 7: Blood Banking & Transfusion Medicine

7.1 Blood Donor Selection, Screening, Collection, and Component Storage 7.2 Transfusion Practice, Indications for Blood Components, and Administration 7.3 Transfusion Reactions: Investigation Protocol and Reaction Classification

8 Chapter 8: Clinical Microbiology

8.1 Specimen Processing, Gram Stain, and Aerobic Gram-Positive Cocci 8.2 Gram-Negative Bacilli: Enterobacteriaceae, Non-Fermenters, and Fastidious Organisms 8.3 Anaerobic Bacteria, Mycobacteria, Acid-Fast Stains, and Molecular Diagnostic Methods 8.4 Clinical Mycology and Medical Parasitology 8.5 Antimicrobial Susceptibility Testing, Resistance, and Virology

9 Chapter 9: Urinalysis & Body Fluids

9.1 Physical and Chemical Examination of Urine and Reagent Strip Principles 9.2 Microscopic Urinalysis: Cells, Casts, Crystals, and Renal Pathology 9.3 Analysis of Cerebrospinal Fluid (CSF), Serous Fluids, and Synovial Fluid

2.7 Lipids, Lipoproteins, and the Friedewald LDL Calculation

Key Takeaways Explain This Topic AI

Major plasma lipids include cholesterol and triglycerides transported in chylomicrons, VLDL, LDL, and HDL.

Friedewald LDL-C (mg/dL) = Total cholesterol − HDL-C − (Triglycerides / 5) when TG are fasting and under 400 mg/dL.

Do not use Friedewald when triglycerides are 400 mg/dL or higher, in nonfasting samples for that formula, or when type III dyslipidemia is suspected—use a direct LDL method.

Desirable adult targets are commonly LDL-C under 100 mg/dL (lower for very high ASCVD risk), HDL-C at least 40 mg/dL in men and 50 mg/dL in women, and triglycerides under 150 mg/dL (guideline-dependent).

Last updated: July 2026

Lipids, Lipoproteins, and Coronary Risk Assessment

Lipids are a dedicated AMT Chemistry work-area topic. Medical Laboratory Scientists measure cholesterol fractions and triglycerides to assess atherosclerotic cardiovascular disease (ASCVD) risk and to monitor therapy.

Lipid Metabolism Essentials

Triglycerides (TG): Glycerol + three fatty acids; primary energy storage lipid. Elevated after meals; fasting specimens are preferred for classic risk panels and Friedewald calculation.

Cholesterol: Structural membrane lipid and steroid/bile-acid precursor. Travels in plasma only inside lipoproteins.

Lipoprotein classes (largest/lightest → smallest/densest):

Chylomicrons — dietary TG from intestine (apoB-48).

VLDL — endogenous TG from liver (apoB-100).

LDL — major cholesterol carrier to tissues (apoB-100); high LDL-C drives atherogenesis.

HDL — reverse cholesterol transport to liver (apoA-I); higher HDL-C is generally protective.

Desirable Levels and Risk Context

Exact cutoffs evolve with guidelines, but MLS exams commonly expect these adult reference concepts (mg/dL):

LDL-C: Optimal <100; near optimal 100–129; borderline 130–159; high 160–189; very high ≥190.

HDL-C: Low (risk) <40 (men) or <50 (women); higher is better.

Triglycerides: Desirable <150; very high ≥500 raises pancreatitis risk.

Total cholesterol: Desirable <200.

Non-HDL-C (total − HDL) and apoB are increasingly used clinically, but classic board items still emphasize LDL-C and the Friedewald equation.

Analytical Methods

Enzymatic assays dominate routine total cholesterol, HDL-C, and triglyceride measurement.

HDL is measured after precipitating apoB-containing lipoproteins or by direct homogeneous methods.

Direct LDL assays measure LDL-C without calculation and are preferred when Friedewald assumptions fail.

Severe icterus, hemolysis, or lipemia can interfere optically—lipemic specimens may need ultracentrifugation or clearing protocols per lab policy.

Friedewald LDL Calculation (High-Yield)

When a direct LDL is not reported, LDL-C is often estimated:

LDL-C (mg/dL) = Total cholesterol − HDL-C − (Triglycerides / 5)

The TG/5 term estimates VLDL-C in mg/dL (use TG/2.2 if units are mmol/L—know which unit system the question uses).

Worked Example

Total cholesterol = 240 mg/dL, HDL-C = 40 mg/dL, TG = 150 mg/dL.

VLDL-C ≈ 150/5 = 30.

LDL-C ≈ 240 − 40 − 30 = 170 mg/dL (high).

  • When Friedewald Is Invalid
  • Triglycerides ≥ 400 mg/dL
  • Nonfasting specimens (for this formula)
  • Suspected type III dyslipoproteinemia (remnant accumulation)
  • Very low TG where VLDL estimation is unreliable in some protocols

In these cases, order or report a direct LDL-C .

Clinical Correlation Scenarios

Isolated high TG + low HDL: metabolic syndrome / diabetes pattern.

Extremely high TG (>1000 mg/dL): consider acute pancreatitis risk and chylomicronemia.

High LDL with tendon xanthomas / premature CAD: consider familial hypercholesterolemia workup.

Mastering lipid panels means calculating correctly, knowing method limitations, and linking patterns to coronary risk—not merely memorizing a single cutoff.

Specimen Collection and Preanalytical Issues for Lipid Panels

For classic Friedewald reporting, collect a fasting specimen (typically 9–12 hours, water allowed). Nonfasting triglycerides rise and can falsely lower calculated LDL-C. Note the collection time and fasting status on the requisition when policy requires it.

Preanalytical traps:

Prolonged tourniquet use concentrates proteins and lipids.

IV contamination from lipid emulsions (TPN) can create extreme lipemia unrelated to endogenous metabolism.

Standing vs supine posture slightly alters concentrations; use consistent outpatient technique.

If the specimen is grossly lipemic, document interference checks; some assays need dilution, ultracentrifugation, or lipemia-clearing reagents before releasing results.

Metabolic Pathways Worth Memorizing

Exogenous pathway: Dietary TG → chylomicrons → lipoprotein lipase (LPL) releases free fatty acids → chylomicron remnants cleared by the liver.

Endogenous pathway: Hepatic VLDL → LPL → IDL → LDL.

Reverse transport: Peripheral cholesterol → HDL → liver (SR-B1) for excretion as bile acids.

ApoB-100 marks atherogenic particles (VLDL, IDL, LDL). ApoA-I marks HDL. Questions may ask which apolipoprotein is on LDL vs HDL—answer apoB-100 vs apoA-I.

Secondary Causes and Drug Effects

Secondary dyslipidemia patterns commonly tested:

Uncontrolled diabetes mellitus → high TG, low HDL.

Nephrotic syndrome → high cholesterol/LDL from hepatic overproduction.

Hypothyroidism → elevated total cholesterol/LDL.

Thiazides, beta-blockers, corticosteroids, and retinoids can worsen lipid profiles—correlate with medication history when results suddenly change.

Quality Control and Reporting Tips

Verify the arithmetic: Total cholesterol should approximately equal HDL + LDL + (TG/5) when Friedewald is used; large imbalances suggest transcription or assay error.

If TG ≥400 mg/dL, cancel/suppress calculated LDL and reflex or recommend direct LDL .

Panic or critical callbacks are lab-specific, but extremely high TG (e.g., >1000 mg/dL) warrant rapid clinician notification because of pancreatitis risk.

Report units clearly (mg/dL vs mmol/L). Never mix unit systems inside the Friedewald equation.

With these preanalytical, pathway, secondary-cause, and QC details, lipid testing becomes a complete Chemistry domain skill rather than a single formula to memorize.